市場調査レポート
商品コード
1426128
眼科機器の世界市場の評価:製品別、エンドユーザー別、地域別、機会、予測(2017年~2031年)Ophthalmic Equipment Market Assessment, By Product, By End-user, By Region, Opportunities and Forecast, 2017-2031F |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
眼科機器の世界市場の評価:製品別、エンドユーザー別、地域別、機会、予測(2017年~2031年) |
出版日: 2024年02月16日
発行: Market Xcel - Markets and Data
ページ情報: 英文 229 Pages
納期: 3~5営業日
|
世界の眼科機器の市場規模は、2023年の554億9,000万米ドルから2031年に813億6,000万米ドルに達し、予測期間の2024年~2031年にCAGRで4.9%の成長が見込まれています。老年人口の増加が市場を牽引しています。年齢が上がるにつれて、慢性疾患を患う人々も増加します。白内障、加齢黄斑変性症(AMD)、糖尿病性網膜症などの眼疾患の有病率の高さも、市場の大きな促進要因となっています。市場の拡大は、眼科手術件数の増加や手術を受ける患者数の増加にも起因しています。
さらに、世界の眼科機器市場は、最先端の眼科手術機器の開発に向けた研究開発への政府からの多額の資金援助や、この部門の主要企業による新しい眼病治療機器の導入から恩恵を受けると予測されます。さらに、肥満率の上昇や、座りがちで活動的でないライフスタイルの増加が、眼科機器へのニーズを高めています。低悪性度の全身性炎症は、座りがちな生活(SB)と関連しており、ドライアイ(DED)の発症に寄与している可能性があります。これらの要因が相まって、世界の眼科機器市場は大きく成長すると予測されており、急速に高齢化が進み、慢性眼疾患の有病率が上がっている北米が市場をリードしています。
眼疾患の有病率の増加
眼疾患の有病率の増加は、世界の眼科機器市場の成長拡大に大きく寄与しています。世界中で少なくとも22億人が近視または遠視を患っています。視覚障害と失明のもっとも一般的な2つの原因は、白内障と屈折異常です。白内障による視力障害を持つ人の17%、屈折異常による遠方視力障害を持つ人の36%しか、世界中で適切な治療を受けていないと予測されています。視力障害が世界に与える経済的負担は大きく、年間の生産損失は4,110億米ドルと推定されています。あらゆる年齢層の人が視力障害の影響を受ける可能性がありますが、失明または視力障害を持つ人のほとんどは50歳以上です。
技術の進歩
技術の進歩が世界の眼科機器市場を牽引しています。近年の技術開発は、世界の眼科医療の提供に革命をもたらし、予防可能な失明を減少させる可能性を持っています。多数のレンズ、対物レンズ、カメラ、超音波センサー、赤外線センサー、レーザーセンサーなどの統合は、世界の眼科機器市場における技術の進歩によって実現可能になっています。検眼と眼科はAIの影響も受けています。現在のところ、この技術は加齢黄斑変性や黄斑浮腫のような病態を追跡するグラフの作成、病変の特定、糖尿病網膜症のスクリーニング、特定の疾患の進行状況の追跡などにも使用できます。近いうちにツールが利用できるようになる見込みですが、AIは現在、眼疾患の診断や予測、疾患の進行に応じた視力の概算などの研究に利用されています。
例えば、Zeiss Medical TechnologyとBoehringer Ingelheimは2023年10月、AIを用いた眼疾患の予測分析を開発するための長期的な戦略的合意を締結しました。両社は眼科技術、データアナリティクス、アルゴリズム、治療法開発における知識を結集し、網膜疾患を早期に発見および治療し、永続的な視力低下を回避することを目指しています。
政府の取り組み
世界各国の政府は、眼科機器産業を支援するために数多くの取り組みを行っています。最先端の眼科手術機器を開発する研究開発に対する多額の政府支出や、市場の主要企業による新しい眼病治療機器の導入が、市場を牽引すると予測されます。医療支出を拡大し、医療インフラをアップグレードする政府の施策も、眼科機器市場を後押ししています。例えば、インド政府保健家族福祉省が発表した2021年~2022年度の年次レポートでは、National Programme for Control of Blindness and Visual Impairment(NPCBVI)に導入された変更が明らかにされています。このプログラムでは、National Health Mission(NHM)の仕組みの中で、一次/二次眼科医療サービスを提供することになります。資金調達の取り決めでは、中央政府と州が60:40の割合で費用を分担することになっています(北東部州やその他の丘陵州では90:10)。
当レポートでは、世界の眼科機器市場について調査分析し、市場規模と予測、市場力学、主要企業情勢と見通しなどを提供しています。
Global ophthalmic equipment market is projected to witness a CAGR of 4.9% during the forecast period 2024-2031, growing from USD 55.49 billion in 2023 to USD 81.36 billion in 2031. The rising aging population drives the global ophthalmic equipment market. With increasing age, the tendency of people suffering from chronic diseases also increases. The high prevalence of eye conditions, such cataracts, age-related macular degeneration (AMD), and diabetic retinopathy, are acting as another major factor driving the global ophthalmic equipment market. The expansion of the global ophthalmic equipment market can also be attributed to the rising number of ophthalmic surgeries and the growing number of patients having surgical treatments.
Moreover, the global ophthalmic equipment market is anticipated to gain from significant government funding for R&D to create cutting-edge ophthalmic surgical equipment and from the introduction of novel eye disease treatment devices by major businesses in the sector. Additionally, driving the need for ophthalmic devices are the rising rates of obesity and the growing sedentary and inactive lifestyles. Low-grade systemic inflammation has been associated with sedentary behaviour (SB) and may contribute to the development of dry eye disease (DED). These factors combined are predicted to cause the global ophthalmic equipment market to grow significantly, with North America leading the market due to its rapidly ageing population and rising prevalence of chronic eye conditions.
Increasing Prevalence of Ocular Conditions
Rising prevalence of ocular conditions greatly contributes to increasing growth of global ophthalmic equipment market. At least 2.2 billion people worldwide suffer from a near- or far-sightedness. The two most common causes of visual impairment and blindness are cataracts and refractive errors. It is predicted that only 17% of individuals with cataract-related vision impairment and 36% of people with refractive error-related distant vision impairment have access to the right kind of intervention worldwide. A significant financial burden on the world is posed by vision impairment; the yearly cost of lost production is estimated to be USD 411 billion. Individuals of all ages can be affected by vision loss, but most of them who have blindness or vision impairment are over 50.
Technological Advancements
Advancements in technology are driving the global ophthalmic equipment market. Recent technology developments have the potential to revolutionise the provision of ophthalmic care globally and lower preventable blindness. The integration of many lenses, objectives, cameras, ultrasonic, infrared, and laser sensors, among other devices, has been made feasible by technological advancements in the global ophthalmic equipment market. Optometry and ophthalmology have also been affected by artificial intelligence (AI). As of right now, this technique can also be used to create graphs to follow pathologies like age-related macular degeneration or macular oedema, identify lesions, screen for diabetic retinopathy, and track the advancement of certain diseases. Although it is anticipated that tools will soon be available, AI is now being used to research diagnostic and predictive aspects for ocular illnesses, as well as the approximated calculation of visual acuity according to the disease's evolution.
For example, Zeiss Medical Technology and Boehringer Ingelheim signed a long-term strategic agreement in October 2023 to develop predictive analytics for eye illnesses using AI. The firms aim to pool their combined knowledge in ophthalmological technology, data analytics, algorithms, and therapy development to detect and treat retinal illnesses in their early stages and avert permanent vision loss.
Government Initiatives
Governments across the world are taking numerous initiatives to support the ophthalmic equipment industry. Significant government spending on R&D to create cutting-edge ophthalmic surgical equipment and the introduction of novel eye disease treatment devices by major companies in the market are anticipated to drive the market. Government measures to expand healthcare spending and upgrade healthcare infrastructure are also fueling the market for ophthalmic devices. For instance, 2021-22 Annual Report released by the Ministry of Health and Family Welfare, Government of India, reveals the changes that have been introduced to the National Programme for Control of Blindness and Visual Impairment (NPCBVI). The program will now offer primary and secondary eye care services within the National Health Mission (NHM) structure. The funding arrangement involves a 60:40 cost division between the Central Government and the State (90:10 in North-Eastern States and other hilly States).
The goal of the National Health Policy (NHP) is to bring the prevalence of blindness down to 0.25 percent by 2025. Grant-in-aid is primarily given for cataract operations, treatment/management of other eye diseases, eye banks and eye donation centres, free eyeglasses distribution to schoolchildren (to District Health Societies, DHSs), training of paramedical ophthalmic assistants (PMOAs), and other paramedics and upkeep of ophthalmic equipment.
Growing Demand for Femtosecond Laser
The increasing demand for femtosecond lasers has greatly contributed to the growth of the global ophthalmic equipment market. The primary factors contributing to this growth are the increasing number of cataract procedures across the globe, advances in laser technology, and the rising prevalence of eye illnesses like cataracts. Femtosecond lasers are primarily used to treat cataract, with their benefits mainly seen in femtosecond laser-assisted cataract surgery. These include standardised corneal incisions, precisely centred, circular capsulorhexis, and lens nucleus fragmentation-even in eyes with hard cataracts. The real-time OCT software programmes, which span the entire anterior segment up to the posterior lens capsule, are responsible for the laser's precision. Femtosecond lasers are extremely effective because they are precise, safe, and give patients the best possible visual outcomes.
For example, in June 2023, the highly anticipated release of VISUMAX 800 and Quatera 700, two of ZEISS's state-of-the-art medical devices in Bangladesh, was announced by the company, a global leader in optics and optoelectronic technology. A cutting-edge femtosecond laser platform, the VISUMAX 800 offers previously unheard-of safety and precision in a range of ophthalmic treatments.
Cataract Surgery Devices are Transforming the Market
Significant advancements and growing demand for cataract surgery devices are transforming the global ophthalmic equipment market. Devices, such as phacoemulsification machines, intraocular lenses (IOLs), and femtosecond lasers, provide more accurate and less invasive cataract removal methods. This change is in response to the increasing number of elderly people globally, who are more susceptible to cataracts. Additionally, improvements in IOLs, including multifocal and toric lenses, are enhancing the quality of vision after surgery, leading to higher patient satisfaction. The combination of these technological improvements, enhanced awareness, and greater accessibility is driving market expansion, making cataract surgery more efficient, safer, and easily accessible.
For example, the worldwide eye health business Johnson & Johnson Vision introduced the ELITA Femtosecond Laser vision correction in Korea on November 23, 2023, and the new TECNIS PureSee IOL for cataract surgery on the same day. TECNIS PureSee is a multi-focal intraocular lens that targets to improve both near and far vision, providing cataract patients with an opportunity to perform and enjoy everyday tasks, such as cooking, driving, and watching TV, without the need for reading glasses.
Future Market Scenario (2024-2031F)
The global ophthalmic equipment market has a very promising future, with substantial increase anticipated in the upcoming years. Key drivers for the anticipated expansion include the rising frequency of eye ailments, the expanding need for surgical and visual care devices, and the increasing prevalence of ocular conditions, including cataracts and glaucoma. The growing use of digital devices like laptops, computers, e-readers, and smartphones is also anticipated to help the industry, as these gadgets are predicted to drive the ophthalmic devices market.
In line with this, the global ophthalmic equipment market is growing because of various measures taken by governments worldwide to assist the ophthalmic equipment sector. Along with significant government funding for research and development to create cutting-edge ophthalmic surgical equipment, the market is anticipated to gain from the introduction of novel eye disease treatment devices by major players in the sector.
Key Players Landscape and Outlook
Companies in the global ophthalmic equipment market are merging and acquiring one another to broaden their range of products, improve their technological prowess, and obtain a competitive advantage. The need for new facilities to house the growing number of ophthalmology clinics, the rising incidence of eye problems, and the growing demand for sophisticated ophthalmic technology are the main drivers of these mergers and acquisitions. These businesses are concentrating on new product development, as well as ongoing research and development, to produce cutting-edge technology, which is spurring the expansion of the sector.
For example, in January 2023, the international contract research company TFS HealthScience announced that it strategically purchased Appletree CI Group to augment its current proficiency in the intricate domains of ophthalmology, dermatology, medical devices, and paediatric studies and broaden its clientele's geographic reach. Becoming a market leader in ophthalmic research is a goal that TFS HealthScience will further with the strategic purchase of Appletree.
All segments will be provided for all regions and countries covered
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work